Bill Text: US HR1179 | 2009-2010 | 111th Congress | Introduced
Bill Title: Expressing the sense of the House of Representatives that biotechnology firms meeting small business standards are critical to the United States, its people and its economy because they create new medicines, services, and jobs and meet unmet needs related to populations and patients with infectious and chronic diseases, including those of medically underserved populations.
Spectrum: Partisan Bill (Democrat 2-0)
Status: (Introduced - Dead) 2010-03-12 - Referred to the House Committee on Energy and Commerce. [HR1179 Detail]
Download: US_Congress-2009-HR1179-Introduced.pdf